Media
BetaLife wins Cytiva’s first BioChallenge Competition in Southeast Asia by Cytiva on 7th Jun 2023 (https://www.cytivalifesciences.com/en/us/news-center/betalife-wins-cytivas-biochallenge-competition-10001)
BetaLife was featured in science news “BetaLife and A*STAR Collaborate to develop next generation cell-based therapy for diabetes treatment” by Bioengineer.org on 22nd March 2023 (https://bioengineer.org/betalife-and-astar-collaborate-to-develop-next-generation-cell-based-therapy-for-diabetes-treatment).
Our Co-Founder Dr Adrian Teo featured in a video “Supporting Science Globally: A look into how scientists in Singapore are using organoids” by STEMCELL Technologies on 20th August 2020 (https://www.youtube.com/watch?v=GzMcF4QUdC8).
Our Co-Founder Dr Adrian Teo featured in a story “Entrepreneurial King of the Lab” in the 3rd February 2020 issue of SGInnovate’s white paper on deep tech talent (https://www.sginnovate.com/blog/future-jobs).
Our Co-Founder Dr Adrian Teo and his research team’s work featured in a story “Weaponizing Stem Cells in the War on Diabetes” in Issue 15, July – December 2019, of A*STAR Research.
Our Co-Founder Dr Adrian Teo featured in a cover story “Stem Cells Gaining Importance” in the August 2019 issue of BioSpectrum Asia on stem cell therapies in APAC.
Our Co-Founder Dr Adrian Teo featured on The Stem Cell Podcast Episode 142: “Beta-Cell Proliferation and Diabetes” (https://stemcellpodcast.com/ep-142-b-cell-proliferation-and-diabetes-featuring-dr-adrian-teo; https://content.blubrry.com/stemcellpodcast/SCP142.mp3) held on May 14, 2019.
Our Co-Founders Dr Adrian Teo and Dr Natasha Ng’s research work featured in a story https://research.a-star.edu.sg/articles/highlights/getting-to-the-roots-of-early-onset-diabetes/
Our Press Release
BetaLife and A*STAR Collaborate to Develop Next Generation Cell-based Therapy for Diabetes Treatment
BetaLife has acquired the rights to human iPSC technology and cell lines from A*STAR BetaLife and A*STAR sign research...